2023³â ´ëÇѺҾÈÀÇÇÐȸ Ãá°èÇмú´ëȸ (¹Ì·¡°¡ ºÒ¾ÈÇÏ´Ù: ÀÀ´äÇ϶ó 2023) : 2023-06-09
±³À°ÀÏÀÚ : 2023-06-09
±³À°Àå¼Ò : ½ºÀ§½º±×·£µåÈ£ÅÚ
±³À°ÁÖÁ¦ : "2023³â ´ëÇѺҾÈÀÇÇÐȸ Ãá°èÇмú´ëȸ (¹Ì·¡°¡ ºÒ¾ÈÇÏ´Ù: ÀÀ´äÇ϶ó 2023)"
ÁÖÃÖ±â°ü : ´ëÇѽŰæÁ¤½ÅÀÇÇÐȸ
½ÃÇà±â°ü(ÁöºÎ/°ú) : ´ëÇѺҾÈÀÇÇÐȸ (ÀÌ»çÀåÁ¦)
´ã´çÀÚ : ´ëÇѺҾÈÀÇÇÐȸ »ç¹«±¹
¿¬¶ôó : 031-787-7434
À̸ÞÀÏ : benzcl500@naver.com
±³À°Á¾·ù : Á¤½Å°Ç°ÀÇÇаú
Âü¼®¿¹»óÀÎ : 300¸í
Èñ¸ÁÆòÁ¡ : 6Á¡
Áö¿ª : ¼¿ïƯº°½Ã
±³À°½Ã°£ : 12 ½Ã°£ 40ºÐ
¼¼ºÎ¼ö°·á : 60,000¿ø
ºñ°í "»çÀüµî·Ïºñ - [ȸ¿øÀü¹®ÀÇ 4¸¸¿ø], [ºñȸ¿øÀü¹®ÀÇ 5¸¸¿ø], [±ºÀü¹®ÀÇ,°øº¸ÀÇ,Àü°øÀÇ 3¸¸¿ø]
ÇöÀåµî·Ïºñ - [ȸ¿øÀü¹®ÀÇ 5¸¸¿ø], [ºñȸ¿øÀü¹®ÀÇ 6¸¸¿ø], [±ºÀü¹®ÀÇ,°øº¸ÀÇ,Àü°øÀÇ 4¸¸¿ø], [Æò»ýȸ¿ø¸éÁ¦:»çÀü,ÇöÀå]"
±¸ºÐ ¿ùÀÏ °ÀÇ½Ç ½Ã°£ ±³À°Á¦¸ñ °»ç¸í(¼Ò¼Ó) Çʼö°ú¸ñ
±³À°½Ã°£ 06¿ù 09ÀÏ ½ºÀ§½º±×·£µåÈ£ÅÚ ±×·£µåº¼·ëA 09:30~09:55 Hurdles of Psychosurgery for Anxiety Disorders: Effects and Side Effects ÀåÁø±¸(¸íÁöº´¿ø)
±³À°½Ã°£ 06¿ù 09ÀÏ ½ºÀ§½º±×·£µåÈ£ÅÚ ±×·£µåº¼·ëA 09:55~10:20 Development of Lesioning Procedure: Experience from MRgFUS capsulotomy Á¤ÇöÈ£(¿¬¼¼ÀÇ´ë ½Å°æ¿Ü°ú)
±³À°½Ã°£ 06¿ù 09ÀÏ ½ºÀ§½º±×·£µåÈ£ÅÚ ±×·£µåº¼·ëA 10:20~10:45 Development of Neuromodulation: Experience from DBS for OCD and Tourette ÀÌÁ¤ÇÑ(¿¬¼¼ÀÇ´ë)
Åä·Ð 06¿ù 09ÀÏ ½ºÀ§½º±×·£µåÈ£ÅÚ ±×·£µåº¼·ëA 10:45~11:00 ÁúÀÇÀÀ´ä ()
±³À°½Ã°£ 06¿ù 09ÀÏ ½ºÀ§½º±×·£µåÈ£ÅÚ ±×·£µåº¼·ëA 11:10~12:00 ºÒ¾ÈÀ» ¸¶ÁÖÇÏ´Â Á¤½Å°Ç°ÀÇÇаú Àǻ簡 ¾Ë¾Æ¾ß ÇÒ Á¤½Å¿ªµ¿°ú Á¤½ÅÄ¡·á ¹Ú¿ëõ(¹Ú¿ëõÁ¤½Å°Ç°ÀÇÇаú)
±³À°½Ã°£ 06¿ù 09ÀÏ ½ºÀ§½º±×·£µåÈ£ÅÚ ±×·£µåº¼·ëA 12:10~12:35 Beyond Response: Aiming for Quality Remission in Depression °ÁöÀÎ(¿¬¼¼ÀÇ´ë)
±³À°½Ã°£ 06¿ù 09ÀÏ ½ºÀ§½º±×·£µåÈ£ÅÚ ±×·£µåº¼·ëA 12:35~13:00 Antidepressant Medication : What factors should be considered? ¹®Àº¼ö(ºÎ»êÀÇ´ë)
Åä·Ð 06¿ù 09ÀÏ ½ºÀ§½º±×·£µåÈ£ÅÚ ±×·£µåº¼·ëA 13:00~13:10 ÁúÀÇÀÀ´ä ()
±³À°½Ã°£ 06¿ù 09ÀÏ ½ºÀ§½º±×·£µåÈ£ÅÚ ±×·£µåº¼·ëA 13:20~13:45 Chat GPT°¡ ¾ð¾î¸¦ ÀÌÇØÇÏ°í ¸¸µé¾î³»´Â ¹æ¹ý ÀüÅÂÁØ(¼¿ï¾Æ»êº´¿ø ºòµ¥ÀÌÅÍ¿¬±¸¼¾ÅÍ)
±³À°½Ã°£ 06¿ù 09ÀÏ ½ºÀ§½º±×·£µåÈ£ÅÚ ±×·£µåº¼·ëA 13:45~14:10 ÀÇ·áºÐ¾ß¿¡¼ ´ëÈÇü ÀΰøÁö´ÉÀÇ È°¿ë: ÇöÀç¿Í ¹Ì·¡ Á¤±Ôȯ(¼º±Õ°ü´ë »ï¼ºÀ¶ÇÕÀÇ°úÇпø)
±³À°½Ã°£ 06¿ù 09ÀÏ ½ºÀ§½º±×·£µåÈ£ÅÚ ±×·£µåº¼·ëA 14:10~14:35 Á¤½Å°Ç°ÀÇÇаú¿¡¼ ´ëÈÇü ÀΰøÁö´ÉÀº ¾î¶»°Ô »ç¿ëµÉ ¼ö ÀÖÀ»±î? ¿ÀÁöÈÆ(°¡Å縯ÀÇ´ë)
Åä·Ð 06¿ù 09ÀÏ ½ºÀ§½º±×·£µåÈ£ÅÚ ±×·£µåº¼·ëA 14:35~14:50 ÁúÀÇÀÀ´ä ()
±³À°½Ã°£ 06¿ù 09ÀÏ ½ºÀ§½º±×·£µåÈ£ÅÚ ±×·£µåº¼·ëA 15:00~15:20 Virtual Care for Mood & Anxiety Disorder Á¤¿µÀº(Á¦ÁÖÀÇ´ë)
±³À°½Ã°£ 06¿ù 09ÀÏ ½ºÀ§½º±×·£µåÈ£ÅÚ ±×·£µåº¼·ëA 15:20~15:40 Overseas Models ÀÌÀçÇå(ij³ª´Ù ¿þ½ºÅϽ¶¸¯ÀÇ´ë)
±³À°½Ã°£ 06¿ù 09ÀÏ ½ºÀ§½º±×·£µåÈ£ÅÚ ±×·£µåº¼·ëA 15:40~16:00 Strengths & Weakness of Current Virtual Care ¹Ú¼±Ã¶(ÇѾçÀÇ´ë)
±³À°½Ã°£ 06¿ù 09ÀÏ ½ºÀ§½º±×·£µåÈ£ÅÚ ±×·£µåº¼·ëA 16:00~16:20 Legal and Technological Issues of Current Virtual Care Á¤Çö°(°í·ÁÀÇ´ë)
Åä·Ð 06¿ù 09ÀÏ ½ºÀ§½º±×·£µåÈ£ÅÚ ±×·£µåº¼·ëA 16:20~16:30 ÁúÀÇÀÀ´ä ()
±³À°½Ã°£ 06¿ù 09ÀÏ ½ºÀ§½º±×·£µåÈ£ÅÚ ±×·£µåº¼·ëC 09:30~09:55 ¹üºÒ¾ÈÀå¾Ö Áø´Ü ¹× Ä¡·á¿Í °ü·ÃµÈ Àνĵµ Á¶»ç °á°ú ±è¹Î°æ(Â÷ÀÇ°úÇдë)
±³À°½Ã°£ 06¿ù 09ÀÏ ½ºÀ§½º±×·£µåÈ£ÅÚ ±×·£µåº¼·ëC 09:55~10:20 ÀÓ»ó¿¡¼ ¹üºÒ¾ÈÀå¾Ö Áø´ÜÀ» °¡·Á³»±â À§ÇÑ Á¢±Ù À±¼®È£(¿µ³²ÀÇ´ë)
±³À°½Ã°£ 06¿ù 09ÀÏ ½ºÀ§½º±×·£µåÈ£ÅÚ ±×·£µåº¼·ëC 10:20~10:45 ´Ù¸¥ Á¤½ÅÀå¾Ö Ä¡·á¿Í ±¸º°µÇ´Â ¹üºÒ¾ÈÀå¾Ö Ä¡·á¿¡ ´ëÇÑ Á¢±Ù ¾È¸íÈñ(¼¿ï¾Æ»êº´¿ø)
Åä·Ð 06¿ù 09ÀÏ ½ºÀ§½º±×·£µåÈ£ÅÚ ±×·£µåº¼·ëC 10:45~11:00 ÁúÀÇÀÀ´ä ()
±³À°½Ã°£ 06¿ù 09ÀÏ ½ºÀ§½º±×·£µåÈ£ÅÚ ±×·£µåº¼·ëC 11:10~12:00 ºÒ¾ÈÀ» ¸¶ÁÖÇÏ´Â Á¤½Å°Ç°ÀÇÇаú Àǻ簡 ¾Ë¾Æ¾ß ÇÒ Á¤½Å¿ªµ¿°ú Á¤½ÅÄ¡·á ¹Ú¿ëõ(¹Ú¿ëõÁ¤½Å°Ç°ÀÇÇаú)
±³À°½Ã°£ 06¿ù 09ÀÏ ½ºÀ§½º±×·£µåÈ£ÅÚ ±×·£µåº¼·ëC 12:10~12:35 Unique Efficacy and Safety of Vortioxetine in Patients with MDD ±èÁö¼±(¼øõÇâÀÇ´ë)
±³À°½Ã°£ 06¿ù 09ÀÏ ½ºÀ§½º±×·£µåÈ£ÅÚ ±×·£µåº¼·ëC 12:35~13:00 Effectiveness of Vortioxetine in Patients with MDD Comorbid with GAD ¹é¸íÀç(°æÈñÀÇ´ë)
Åä·Ð 06¿ù 09ÀÏ ½ºÀ§½º±×·£µåÈ£ÅÚ ±×·£µåº¼·ëC 13:00~13:10 ÁúÀÇÀÀ´ä ()
±³À°½Ã°£ 06¿ù 09ÀÏ ½ºÀ§½º±×·£µåÈ£ÅÚ ±×·£µåº¼·ëC 13:20~13:45 µðÁöÅÐ ¹Ìµð¾î°¡ ºÒ¾È¿¡ ¹ÌÄ¡´Â ¿µÇâ ÀÌÇö¾Æ(¼øõÇâÀÇ´ë)
±³À°½Ã°£ 06¿ù 09ÀÏ ½ºÀ§½º±×·£µåÈ£ÅÚ ±×·£µåº¼·ëC 13:45~14:10 ¿Ü·Î¿ò, »çȸÀû °í¸³°ú ¿ì¿ï, ºÒ¾È°úÀÇ °ü°è ¾ÈÁöÇö(¼º±Õ°üÀÇ´ë)
±³À°½Ã°£ 06¿ù 09ÀÏ ½ºÀ§½º±×·£µåÈ£ÅÚ ±×·£µåº¼·ëC 14:10~14:35 »ó½Ç, ¾Öµµ¿Í ºÒ¾È ±è¿ø(ÀÎÁ¦ÀÇ´ë)
Åä·Ð 06¿ù 09ÀÏ ½ºÀ§½º±×·£µåÈ£ÅÚ ±×·£µåº¼·ëC 14:35~14:50 ÁúÀÇÀÀ´ä ()
±³À°½Ã°£ 06¿ù 09ÀÏ ½ºÀ§½º±×·£µåÈ£ÅÚ ±×·£µåº¼·ëC 15:00~15:25 Á¤½ÅÀÇÇÐ ºÐ¾ß ¼ÀûÀÇ ÃֽŠÃâÆÇ µ¿Çâ ÀåÀº¼ö(ÆíÁý¹®È½ÇÇè½Ç)
±³À°½Ã°£ 06¿ù 09ÀÏ ½ºÀ§½º±×·£µåÈ£ÅÚ ±×·£µåº¼·ëC 15:25~15:50 Á¤½Å°Ç°ÀÇÇаú ÀÇ»ç·Î¼ ´ëÁß ¼Àû ÁýÇÊÀÇ ÀÇ¹Ì ÀüÈ«Áø(¼º±Õ°üÀÇ´ë)
±³À°½Ã°£ 06¿ù 09ÀÏ ½ºÀ§½º±×·£µåÈ£ÅÚ ±×·£µåº¼·ëC 15:50~16:15 YouTube, ¹æ¼Û ¹× ´ëÁß °¿¬À» ÅëÇØ ´ëÁß°ú ¼ÒÅëÇϱ⠱èÁö¿ë(¿¬¼¼À£Á¤½Å°Ç°ÀÇÇаú)
Åä·Ð 06¿ù 09ÀÏ ½ºÀ§½º±×·£µåÈ£ÅÚ ±×·£µåº¼·ëC 16:15~16:30 ÁúÀÇÀÀ´ä ()